Long COVID risk falls only slightly after vaccination, huge study shows

3 min read Original article ↗
  • NEWS

Results suggest that vaccines offer less protection against lingering symptoms than expected.

By

  1. Sara Reardon

    1. Sara Reardon is a freelance science journalist based in Bozeman, Montana.

Vaccination against SARS-CoV-2 lowers the risk of long COVID after infection by only about 15%, according to a study of more than 13 million people1. That’s the largest cohort that has yet been used to examine how much vaccines protect against the condition, but it is unlikely to end the uncertainty.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-022-01453-0

References

  1. Al-Aly, Z., Bowe, B. & Xie, Y. Nature Med. https://doi.org/10.1038/s41591-022-01840-0 (2022).

    Article  Google Scholar 

  2. Yoo, S. M. et al. J. Gen. Intern. Med. https://doi.org/10.1007/s11606-022-07523-3 (2022).

    Article  Google Scholar 

  3. Stephenson, T. et al. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-798316/v1 (2021).

  4. Xie, Y., Bowe, B. & Al-Aly, Z. Nature Commun. 12, 6571 (2021).

    Article  PubMed  Google Scholar 

  5. Antonelli, M. et al. Lancet. Infect. Dis. 22, 43–55 (2022).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on: